Davis Polk advised the underwriters in the offering while Jones Day advised GenScript Biotech Corporation. Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering. Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents in the offering. Core Laboratories N.V. (Core Lab) announced its at-the-market offering program under which Core Lab may from time to...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters and dealer managers in the transaction. Motorola Solutions, Inc. announced its registered offering of $600 million aggregate...
You must be a Standard 1 Year member to access this content.
